Effect of the Dose and Duration of Interferon-Alpha Therapy on the Incidence of Hepatocellular Carcinoma in Noncirrhotic Patients with a Nonsustained Response to Interferon for Chronic Hepatitis C

Publisher： Karger

E-ISSN： 1423-0232|61|2|134-142

ISSN： 0030-2414

Source： Oncology, Vol.61, Iss.2, 2001-08, pp. : 134-142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon for Decreasing the Incidence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C

By  

Oncology, Vol. 62, Iss. 1, 2002-01 ,pp. : 87-93

Karger

Access to resources Recommend Favorite

Incidence of Depression in Patients with Chronic Hepatitis C Receiving Combination Therapy of Pegylated Interferon-Alpha and Ribavirin

By  

Psychotherapy and Psychosomatics, Vol. 83, Iss. 5, 2014-08 ,pp. : 308-309

Karger

Access to resources Recommend Favorite

Low-Dose, Long-Term, Intermittent Interferon-alpha-2b Therapy after Radical Treatment by Radiofrequency Ablation Delays Clinical Recurrence in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma

By  

Intervirology, Vol. 48, Iss. 1, 2005-03 ,pp. : 64-70

Karger

Access to resources Recommend Favorite

Long-Term Follow-Up of Chronic Hepatitis C Patients Treated with Interferon-Alpha: Risk of Cirrhosis and Hepatocellular Carcinoma in a Single Center over 10 Years

By  

Intervirology, Vol. 58, Iss. 1, 2015-01 ,pp. : 14-21

Karger

Access to resources Recommend Favorite

Development of Hepatocellular Carcinoma after Interferon Therapy in Chronic Hepatitis C

By  

Intervirology, Vol. 48, Iss. 1, 2005-03 ,pp. : 59-63

Karger

Access to resources Recommend Favorite